• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

2
results for

"Lipiodol"

Filter

Article category

Keywords

Publication year

Authors

"Lipiodol"

Original Article

[English]
MRI Findings of Lipiodol Uptake in Hepatocellular Carcinomas: A Focus on Signal Intensity
Myung Jae Lee, Min Jeong Kim, Seung Yon Baek
Ewha Med J 2016;39(4):110-117.   Published online October 27, 2016
DOI: https://doi.org/10.12771/emj.2016.39.4.110
Objectives

To evaluate MRI findings of non-recurrent hepatocellular carcinomas with lipiodol uptake (LHCCs) treated with transarterial chemoembolization.

Methods

28 LHCCs were divided into two groups according to amount of lipiodol uptake and tumor size, retrospectively. According to amount of lipiodol uptake, HCCs were classified into group A with dense lipiodol uptake (more than 90%) and group B with partial lipiodol uptake (between 50% and 90%). For HCC size analysis, group I was defined by a longest diameter of less than 2 cm, and group II was defined by a longest diameter of greater than or equal to 2 cm.

Results

In group A (n=16), eight LHCCs showed high signal intensity (SI) on T2-weighted images (T2WI), ten LHCCs showed low SI on T1-weighted imaged (T1WI), six LHCCs showed decreased SI at higher b value of diffusion-weighted images (DWI). In group B (n=12), six LHCCs revealed high SI on T2WI, six LHCCs revealed low SI on T1WI, ten LHCCs decreased SI at higher b value of DWI. As compared with tumor size and SI, six of 12 LHCCs in group I and eight of 16 LHCCs in group II showed high SI on T2WI. Six LHCCs in group I and ten LHCCs in group II showed low SI on T1WI. All LHCCs were not enhanced.

Conclusion

Signal intensities of LHCCs were variable, but more than half of LHCCs showed high SI on T2WI, low SI on T1WI, decreased SI at higher b value of DWI, regardless of lipiodol uptake or tumor size.

Citations

Citations to this article as recorded by  
  • Comparison of contrast-enhanced ultrasonography and MRI results obtained by expert and novice radiologists indicating short-term response after transarterial chemoembolisation for hepatocellular carcinoma
    C.-C. Lee, J.-I. Hwang, K.-H. Chang, Y.C. Lin, C.C. Chao, T.-F. Cheng, Y.-C. Chen, K.-C. Hsueh
    Clinical Radiology.2024; 79(1): e73.     CrossRef
  • 86 View
  • 0 Download
  • 1 Crossref
Case Report
[English]
A Case of Lipiodol Pneumonitis After Transarterial Chemoembolization for Hepatocellular Carcinoma
So-I Kim, Yoo-Ri Kim, Hyun-Mi Heo, Suh-Eun Bae, Myung-Won Lee, Yun-Jung Choi, Go-Heun Kim, Tae-Hun Kim, Kwon Yoo, Il-Hwan Moon
Ihwa Ŭidae chi 2009;32(2):85-89.   Published online September 30, 2009
DOI: https://doi.org/10.12771/emj.2009.32.2.85

Hepatocellular carcinoma(HCC)is one of common causes of cancer-related death in Korea where the majority of HCC patients were Hepaitc B virus(HBV)carriers and have cirrhosis. Transarterial chemoembolization(TACE)is commonly applied to the treatment of multinodular HCC in Korea and careful selection of candidate is important for the risk of various side effects. Besides common side effects as fever, nausea, abdominal pain and elevation of liver enzyme, TACE may predispose to hepatic failure, ischemic cholecystitis, pulmonary embolism, cerebral embolism and pneumonitis. In previous studies, some cases of pulmonary and cerebral embolism cases were reported but lipiodol pneumonitis after TACE was rarely reported. A 65-year-old woman with a multinodular HCC associated with HBV infection, was treated with TACE. Seven days after the procedure, nonspecific respiratory symptoms such as dyspnea and dry cough developed. Chest X-ray and chest computed tomography showed diffuse ground glass opacities in whole lung fields, suggestive of lipiodol pneumonitis. After several days of supportive care with steroid administration, radiologic abnormalities and subjective symptoms were much improved, considered that the disease was compatible with lipiodol pneumonitis.

Citations

Citations to this article as recorded by  
  • Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Sungkeun Kim, Hee Yeon Kim, Su Lim Lee, Young Mi Ku, Yoo Dong Won, Chang Wook Kim
    Journal of Liver Cancer.2020; 20(1): 60.     CrossRef
  • 43 View
  • 0 Download
  • 1 Crossref
TOP